Reliability of FEV1/FEV6 to Diagnose Airflow Obstruction Compared with FEV1/FVC: The PLATINO Longitudinal Study

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Perez Padilla, Rogelio ^a   Wehrmeister, Fernando C ^b   Celli, Bartolome R ^c,h   Lopez Varela, Maria Victorina ^d   Montes de Oca, Maria ^e   Muiño, Adriana ^d   Talamo, Carlos ^e   Jardim, Jose R ^f   Valdivia, Gonzalo ^g   Lisboa, Carmen ^g   Menezes, Ana Maria B ^b   Buist, Sonia ^h   Vollmer, William ^h   Torres, Carlos ^h   Luna, Juan ^h   Rodriguez Roisin, Roberto ^h   Márquez, María ^h   Blanco, María ^h   Pacheco, Edilberto ^h   Rosa, Fernanda ^h   Camelier, Aquiles ^h   Franco Marina, Francisco ^h   Corcho, Alexander ^h   Moreno, Dolores ^h   Pertuze, Julio ^h   more..

^a INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^b FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

^c HARVARD MEDICAL SCHOOL   (United States)

^d DEPARTAMENTO DE BIOQUÍMICA   (Uruguay)

^e UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^f FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^g PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^h NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AIRWAY OBSTRUCTION; ARTICLE; BRAZIL; CHILE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; EXHALATION; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEALTH SURVEY; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEXICO; PREVALENCE; RELIABILITY; SMOKING; SPIROMETRY; URBAN AREA; URUGUAY; VENEZUELA; CITY; COMPARATIVE STUDY; FOLLOW UP; LUNG FUNCTION TEST; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; REPRODUCIBILITY; SOUTH AND CENTRAL AMERICA; STATISTICS; VITAL CAPACITY; PROCEDURES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; STATISTICS AND NUMERICAL DATA;

CITIES; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; LATIN AMERICA; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REPRODUCIBILITY OF RESULTS; RESPIRATORY FUNCTION TESTS; SPIROMETRY; VITAL CAPACITY;

EID: 84881002242     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067960     Document Type: Article

References (30)

1. Lundgren FL, Cabral MM, Climaco DC, de Macedo LG, Coelho Mde A, et al. (2007) Determination of the efficacy of FEV6 as a surrogate for FVC in the diagnostic screening for chronic obstructive pulmonary disease through the comparison of FEV1/FVC and FEV1/FEV6 ratios. J Bras Pneumol 33 (2):: 148-151.
2. Enright RL, Connett JE, Bailey WC, (2002) The FEV1/FEV6 predicts lung function decline in adult smokers. Respir Med 96 (6):: 444-449.
3. Jing JY, Huang TC, Cui W, Xu F, Shen HH, (2009) Should FEV1/FEV6 replace FEV1/FVC ratio to detect airway obstruction? A metaanalysis. Chest 135 (4):: 991-998.
4. Lamprecht B, Schirnhofer L, Tiefenbacher F, Kaiser B, Buist SA, et al. (2007) Six-second spirometry for detection of airway obstruction: a population-based study in Austria. Am J Respir Crit Care Med 176 (5):: 460-464.
5. Melbye H, Medbo A, Crockett A, (2006) The FEV1/FEV6 ratio is a good substitute for the FEV1/FVC ratio in the elderly. Primary care respiratory journal: journal of the General Practice Airways Group 15 (5):: 294-298.
6. Rosa FW, Perez-Padilla R, Camelier A, Nascimento OA, Menezes AM, et al. (2007) Efficacy of the FEV1/FEV6 ratio compared to the FEV1/FVC ratio for the diagnosis of airway obstruction in subjects aged 40 years or over. Braz J Med Biol Res 40 (12):: 1615-1621.
7. Vandevoorde J, Verbanck S, Schuermans D, Kartounian J, Vincken W, (2005) FEV1/FEV6 and FEV6 as an alternative for FEV1/FVC and FVC in the spirometric detection of airway obstruction and restriction. Chest 127 (5):: 1560-1564.
8. Perez-Padilla R, Hallal PC, Vazquez-Garcia JC, Muino A, Maquez M, et al. (2007) Impact of bronchodilator use on the prevalence of COPD in population-based samples. COPD 4 (2):: 113-120.
9. Frith P, Crockett A, Beilby J, Marshall D, Attewell R, et al. (2011) Simplified COPD screening: validation of the PiKo-6(R) in primary care. Primary care respiratory journal: journal of the General Practice Airways Group 20 (2):: 190-198, 192 p following 198.
10. Sichletidis L, Spyratos D, Papaioannou M, Chloros D, Tsiotsios A, et al. (2011) A combination of the IPAG questionnaire and PiKo-6(R) flow meter is a valuable screening tool for COPD in the primary care setting. Primary care respiratory journal: journal of the General Practice Airways Group 20 (2):: 184-189, 181 p following 189.
11. Kaufmann M, Hartl S, Geyer K, Breyer MK, Burghuber OC, (2009) Measuring FEV(6) for detecting early airway obstruction in the primary care setting. Quality and utility of the new PiKo-6 device. Respiration 78 (2):: 161-167.
12. Hankinson JL, Crapo RO, Jensen RL, (2003) Spirometric reference values for the 6-s FVC maneuver. Chest 124 (5):: 1805-1811.
13. Hankinson JL, Odencrantz JR, Fedan KB, (1999) Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 159 (1):: 179-187.
14. Pereira CA, Sato T, Rodrigues SC, (2007) New reference values for forced spirometry in white adults in Brazil. J Bras Pneumol 33 (4):: 397-406.
15. Perez-Padilla R, Valdivia G, Muino A, Lopez MV, Marquez MN, et al. (2006) Spirometric reference values in 5 large Latin American cities for subjects aged 40 years or over. Arch Bronconeumol 42 (7):: 317-325.
16. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, et al. (2005) Standardisation of spirometry. Eur Respir J 26 (2):: 319-338.
17. Menezes AM, Victora CG, Perez-Padilla R, (2004) The Platino project: methodology of a multicenter prevalence survey of chronic obstructive pulmonary disease in major Latin American cities. BMC Med Res Methodol 4 (1):: 15.
18. Montes de Oca M, Talamo C, Halbert RJ, Perez-Padilla R, Lopez MV, et al. (2009) Frequency of self-reported COPD exacerbation and airflow obstruction in five Latin American cities: the Proyecto Latinoamericano de Investigacion en Obstruccion Pulmonar (PLATINO) study. Chest 136 (1):: 71-78.
19. Montes de Oca M, Talamo C, Halbert RJ, Perez-Padilla R, Lopez MV, et al. (2009) Health status perception and airflow obstruction in five Latin American cities: the PLATINO study. Respir Med 103 (9):: 1376-1382.
20. Montes de Oca M, Halbert RJ, Lopez MV, Perez-Padilla R, Talamo C, et al. (2012) Chronic bronchitis phenotype in subjects with and without COPD: the PLATINO study. Eur Respir J.
21. Lopez Varela MV, Montes de Oca M, Halbert RJ, Muino A, Perez-Padilla R, et al. (2010) Sex-related differences in COPD in five Latin American cities: the PLATINO study. Eur Respir J 36 (5):: 1034-1041.
22. American Thoracic Society (1995) Standardization of Spirometry, 1994 Update. Am J Respir Crit Care Med 152 (3):: 1107-1136.
23. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, et al. (2007) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176 (6):: 532-555.
24. Hardie JA, Buist AS, Vollmer WM, Ellingsen I, Bakke PS, et al. (2002) Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J 20 (5):: 1117-1122.
25. Vollmer WM, Gislason T, Burney P, Enright PL, Gulsvik A, et al. (2009) Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study. Eur Respir J 34 (3):: 588-597.
26. Perez-Padilla R, Valdivia G, Muino A, Lopez MV, Marquez MN, et al. (2006) Spirometric Reference Values in 5 Large Latin American Cities for Subjects Aged 40 Years or Over. Arch Bronconeumol 42 (7):: 317-325.
27. Perez-Padilla R, Vazquez-Garcia JC, Marquez MN, Menezes AM, (2008) Spirometry quality-control strategies in a multinational study of the prevalence of chronic obstructive pulmonary disease. Respir Care 53 (8):: 1019-1026.
28. Perez-Padilla R, Vazquez-Garcia JC, Marquez MN, Jardim JR, Pertuze J, et al. (2006) The long-term stability of portable spirometers used in a multinational study of the prevalence of chronic obstructive pulmonary disease. Respir Care 51 (10):: 1167-1171.
29. Menezes AM, Perez-Padilla R, Jardim JR, Muino A, Lopez MV, et al. (2005) Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 366 (9500):: 1875-1881.
30. Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, et al. (2007) International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 370 (9589):: 741-750.